Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    IRLAB Therapeutics

    MCap

    SEK653m

    Last close

    SEK14.10

    ▲ 1.50 (11.90%)

    VolitionRx

    MCap

    USD51m

    Last close

    USD0.60

    ▲ 0.05 (9.82%)

    Portobello SpA

    MCap

    EUR12m

    Last close

    EUR2.38

    ▲ 0.20 (9.17%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Numis Corporation (LSE: NUM)

Last close As at 04/11/2024

GBP3.43

— 0.00 (0.00%)

Market capitalisation

GBP402m

Numis is one of the UK’s leading independent corporate advisory and stockbroking groups, offering a full range of research, execution, equity capital markets, corporate broking and advisory services. It employs over 270 staff in offices in London and New York, and at the end of September 2018 had 210 corporate clients.

Latest Insights

View More

Financials | Update

Numis Corporation — Markets still subdued but diversification helps

Financials | Update

Numis — Revenues running in line with H222

Financials | Update

Numis Corporation — Diversification mitigates market downturn

Financials | Update

Numis Corporation — A subdued H222 though M&A outlook positive
Numis-Corporation_resized
Visit Website

Sector

Financials

Balance Sheet

Forecast net debt (£m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 0.3 3.0 89.3
Relative 4.7 9.4 85.6
52 week high/low 343.0p/170.6p

Financials

Edison Investment Research is terminating coverage on Kinarus Therapeutics (KNRS), Numis Corporation (NUM), EMIS Group (EMIS), Pixium Vision (PIX) and Treatt (TET). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Previously published reports can still be accessed via website

Y/E Sep Revenue (£m) EBITDA (£m) PBT (£m) EPS (fd) (p) P/E (x) P/CF (x)
2021A 215.6 72.3 74.2 49.1 7.0 N/A
2022A 144.2 25.6 20.9 11.9 28.8 N/A
2023E N/A N/A N/A N/A N/A N/A
2024E N/A N/A N/A N/A N/A N/A

Research

Numis-Corporation_resized

Update

Financials

Numis — Revenues running in line with H222

Update

Financials

Numis Corporation — Diversification mitigates market downturn

Financials

Update

Numis Corporation — Markets still subdued but diversification helps
View All

Thematics

View All

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free